All Stories

  1. Therapeutic anti‐amyloid β antibodies cause neuronal disturbances

    Article • Alzheimer s & Dementia, December 2022, Wiley

    MOURAD TAYEBI

  2. Detection of retinal and blood Aβ oligomers with nanobodies

    Article • Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, January 2021, Wiley

    MOURAD TAYEBI

  3. Epitope-specific anti-PrP antibody toxicity: a comparative in-silico study of human and mouse prion proteins

    Article • Prion, January 2021, Taylor & Francis

    MOURAD TAYEBI

  4. Treatment of Microglia with Anti-PrP Antibodies Induces Neuronal Allergenicity

    Article • October 2020, Research Square

    MOURAD TAYEBI

  5. Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma

    Article • Scientific Reports, January 2020, Springer Science + Business Media

    MOURAD TAYEBI

  6. Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos

    Article • Scientific Reports, November 2019, Springer Science + Business Media

    Umma Habiba, MOURAD TAYEBI

  7. Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus

    Article • Journal of Immunology Research, October 2018, Hindawi Publishing Corporation

    Utpal Kumar Adhikari, MOURAD TAYEBI

  8. Canine Mixed Mammary Tumour as a Model for Human Breast Cancer with Osseous Metaplasia

    Article • Journal of Comparative Pathology, May 2017, Elsevier

    MOURAD TAYEBI

  9. Detection of Protein Aggregates in Brain and Cerebrospinal Fluid Derived from Multiple Sclerosis Patients

    Article • Frontiers in Neurology, December 2014, Frontiers

    MOURAD TAYEBI

  10. Potential candidate camelid antibodies for the treatment of protein-misfolding diseases

    Article • Journal of Neuroimmunology, July 2014, Elsevier

    MOURAD TAYEBI

  11. PrPSc-Specific Antibodies with the Ability to Immunodetect Prion Oligomers

    Article • PLoS ONE, May 2011, PLOS

    MOURAD TAYEBI

  12. PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein

    Article • Journal of General Virology, March 2011, Society for General Microbiology

    MOURAD TAYEBI

  13. Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis

    Article • Journal of General Virology, August 2010, Society for General Microbiology

    MOURAD TAYEBI

  14. PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein

    Article • Journal of General Virology, August 2010, Society for General Microbiology

    MOURAD TAYEBI

  15. Glycosylphosphatidylinositol Anchor Analogues Sequester Cholesterol and Reduce Prion Formation

    Article • Journal of Biological Chemistry, July 2010, Elsevier

    MOURAD TAYEBI

  16. A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death

    Article • Neuropharmacology, July 2010, Elsevier

    MOURAD TAYEBI

  17. The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication

    Article • Biochemical Journal, April 2010, Portland Press Ltd.

    MOURAD TAYEBI

  18. A Camelid Anti-PrP Antibody Abrogates PrPSc Replication in Prion-Permissive Neuroblastoma Cell Lines

    Article • PLoS ONE, March 2010, PLOS

    MOURAD TAYEBI

  19. Phospholipase A2 inhibitors protect against prion and Aβ mediated synapse degeneration

    Article • Molecular Neurodegeneration, January 2010, Springer Science + Business Media

    MOURAD TAYEBI

  20. Glimepiride Reduces the Expression of PrPC, Prevents PrPSc Formation and Protects against Prion Mediated Neurotoxicity

    Article • PLoS ONE, December 2009, PLOS

    MOURAD TAYEBI

  21. Polyunsaturated Fatty Acids Protect Against Prion-Mediated Synapse Damage In Vitro

    Article • Neurotoxicity Research, July 2009, Springer Science + Business Media

    MOURAD TAYEBI

  22. Unswitched immunoglobulin M response prolongs mouse survival in prion disease

    Article • Journal of General Virology, March 2009, Society for General Microbiology

    MOURAD TAYEBI

  23. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells

    Article • BMC Biology, September 2008, Springer Science + Business Media

    MOURAD TAYEBI

  24. Cholesterol esterification reduces the neurotoxicity of prions

    Article • Neuropharmacology, June 2008, Elsevier

    MOURAD TAYEBI

  25. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2activation

    Article • BMC Biology, February 2008, Springer Science + Business Media

    MOURAD TAYEBI

  26. Ginkgolides protect against amyloid-β1–42-mediated synapse damage in vitro

    Article • Molecular Neurodegeneration, January 2008, Springer Science + Business Media

    MOURAD TAYEBI

  27. A role for B lymphocytes in anti-infective prion therapies?

    Article • Expert Review of Anti-infective Therapy, August 2007, Taylor & Francis

    MOURAD TAYEBI

  28. Antibody-mediated neuronal apoptosis: Therapeutic implications for prion diseases

    Article • Immunology Letters, June 2006, Elsevier

    MOURAD TAYEBI

  29. Protein Conformation Significantly Influences Immune Responses to Prion Protein

    Article • The Journal of Immunology, March 2005, The American Association of Immunologists

    MOURAD TAYEBI

  30. Disease-Associated Prion Protein Elicits Immunoglobulin M Responses In Vivo

    Article • World Journal of Surgery, July 2004, Springer Science + Business Media

    MOURAD TAYEBI

  31. PrPSc Binding Antibodies Are Potent Inhibitors of Prion Replication in Cell Lines

    Article • Journal of Biological Chemistry, May 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vincent Beringue, MOURAD TAYEBI

  32. Regional heterogeneity of cellular prion protein isoforms in the mouse brain

    Article • Brain, September 2003, Oxford University Press (OUP)

    Dr Vincent Beringue, MOURAD TAYEBI

  33. Monoclonal antibodies inhibit prion replication and delay the development of prion disease

    Article • Nature, March 2003, Springer Science + Business Media

    MOURAD TAYEBI